Shares of Forte Biosciences climbed 38% to $28.40 on Thursday after the company reported that its experimental antibody, FB102, demonstrated significant efficacy in a placebo-controlled vitiligo study. The data revealed sustained skin improvements that persisted even after the cessation of treatment, marking a notable milestone for the biotech firm.
Shares of nLight jumped 30% to $76.03 after the company secured a position in the U.S. Department of War’s Joint Laser Weapon System program. This agreement, targeting next-generation cruise missile defense, carries an initial $44 million award and a potential program ceiling reaching $627 million over its lifecycle.
Shares of Neo Performance Materials climbed more than 12% to 42.55 Canadian dollars on Thursday after the firm aggressively lifted its annual earnings forecast. The company now anticipates adjusted EBITDA between 140 million and 150 million Canadian dollars for 2026, marking a sharp departure from its previous target of 110 million.
A Philadelphia Phillies superstar’s video message has landed at the center of a legal battle against the gambling industry, after reports revealed FanDuel commissioned Bryce Harper to record a personal greeting for a customer who had just suffered significant financial losses on the platform.
A 12% drop in Cable One stock on Thursday reflects investor anxiety following the broadband provider’s forecast of sustained subscriber attrition. The company anticipates losing between 16,000 and 18,000 residential data customers in the second quarter, signaling a persistent struggle to maintain its user base in a tightening market.
A 4.2% jump in Greenwich LifeSciences shares followed the European Medicines Agency's clearance of the company’s GP2 active ingredient for use in breast cancer immunotherapy trials. The development marks a significant logistical milestone as the firm expands its reach beyond the United States to combat cancer recurrence.
Investors reacted sharply to MDA Space’s expansion plans Thursday, sending shares down 7.2% to $35.85 in New York trading. The drop followed the Canadian firm's announcement of a $649.1 million deal to acquire a majority stake in satellite services provider Collecte Localisation Satellites, alongside an expanded capital raise.
A 17% jump in Playtech’s London-listed shares followed the gambling-software firm’s announcement that full-year adjusted earnings will significantly outpace market expectations. The company now projects adjusted Ebitda of at least 270 million euros for 2026, shattering the consensus estimate of 219 million euros previously held by analysts.
Steel Partners has launched a $962.8 million takeover bid for InMode, directly challenging a rival buyout led by the medical technology company’s own chief executive. The offer of $16.75 per share aims to undercut the existing proposal from MN Business Strategy, a group that includes CEO Moshe Mizrahy.
A 3% pre-market stock jump signals investor confidence in Voyager Technologies after the firm secured a yearlong contract to develop an agentic-AI spectrum operations platform. The deal marks a significant expansion for the aerospace company, which has seen its share price climb 30% since the beginning of the year.
Grain export figures for the week ending July 2 hit the bottom of market expectations, with corn, wheat, and soybean sales all trailing forecasts. The data, released Thursday by the Department of Agriculture, arrived as traders shed positions in anticipation of the upcoming World Agricultural Supply and Demand Estimates report.
With construction at its Clay, New York facility running a full quarter ahead of schedule, Micron Technology is betting heavily on the AI boom. The chipmaker announced a massive $250 billion commitment to U.S. manufacturing through 2035, aiming to secure a dominant position in the surging global market for memory.
Teva Pharmaceutical Industries is carving out a larger footprint in the specialty medicine market, securing exclusive global rights to a biosimilar version of the multiple sclerosis drug Ocrevus. The move pairs Teva’s regulatory and commercial reach with the manufacturing capacity of Poland’s Polpharma Biologics to challenge a high-profile therapy.
A European managing general agent specializing in short-term car rental coverage will soon join Roadzen's portfolio, marking a $15 million expansion into a high-volume insurance market. The acquired firm currently processes approximately 800,000 policies annually, anchoring Roadzen's strategy to scale its technology-enabled insurance offerings across the continent.
Sam’s Club is integrating Weight Watchers wellness programs directly into its subscription model, aiming to bolster the value of its membership tiers. The partnership grants Plus-level subscribers immediate access to discounted health plans, marking a strategic shift toward incorporating lifestyle and wellness services into the retail giant's core offerings.
Industrial Logistics Properties Trust has moved to double its quarterly distribution, lifting the payout to 10 cents per share from the previous 5 cents. This decision by the Newton, Massachusetts-based real estate investment trust signals a sharp adjustment in shareholder returns following Wednesday's market close.
Sam’s Club is integrating Weight Watchers wellness programs directly into its subscription model, a move aimed at capturing a growing consumer base interested in clinical weight management. The retail giant announced Thursday that it will offer exclusive access to digital health tools and discounted GLP-1 medication support platforms.
A sharp drop in the cost of fresh produce and energy pushed Mexico’s annual inflation rate to 3.37% in June, marking the lowest level recorded in five and a half years. The decline outperformed market expectations, signaling a potential shift in the country’s broader economic landscape.
To scale its battery production, Fremont-based Enovix has tapped Michael Vyvoda, a veteran of Apple’s manufacturing operations, to serve as its new chief operating officer. The appointment, effective July 29, places the 53-year-old in charge of the company’s global supply chain and manufacturing engineering divisions as it seeks to ramp up output.
Owners of 2020 through 2024 Kia Telluride SUVs are being urged to park their vehicles outdoors and away from structures following a massive recall. The safety action targets 462,869 units, as investigators identified a critical defect in the front power seat motor that poses a significant fire risk.
Shares of the Boulder-based technology platform slid 16% in premarket trading to $3.35 after the company set the price for its $22.8 million equity raise. The slide adds to a difficult year for the stock, which had already shed 30% of its value heading into Thursday’s session.
Cerebras Systems is launching a massive 200-megawatt data center network across France, Finland, and Norway, marking the company’s first major entry into the European market. The expansion aims to provide localized, high-speed AI infrastructure to meet surging demand from regional governments, research institutions, and private enterprises alike.
London-based VersaBank is scaling its American consumer lending operations through a new agreement with ECN Capital, granting the financial services provider access to its proprietary Structured Receivable Program. The partnership aims to accelerate loan processing times while bypassing traditional warehouse financing requirements for the firm’s U.S. subsidiary.
Siemens is joining forces with FuelCell Energy to accelerate the deployment of industrial-scale fuel cell power generation. The collaboration targets energy-intensive sectors, combining Siemens’ electrical infrastructure expertise with FuelCell Energy’s proprietary technology to streamline the rollout of commercial power systems exceeding 100 megawatts.
A new operating model, combining Palantir Foundry with Rackspace’s private cloud, aims to bridge the gap between AI ambition and production-grade security. The partnership targets sovereign and regulated enterprises, such as energy providers and healthcare systems, that struggle to integrate large-scale machine learning while maintaining strict data compliance and governance standards.
A 15% jump in premarket trading greeted Simply Good Foods on Thursday, as the packaged-foods company defied market pessimism by raising its full-year sales forecast. The move marks a sharp turnaround for a stock that had suffered a 36% decline since the start of the year.
A 23% premarket collapse greeted Ionis Pharmaceuticals on Thursday after its experimental heart medication, eplontersen, failed a critical late-stage study. The drug, designed to treat transthyretin-mediated amyloid cardiomyopathy, missed its primary efficacy target, leaving investors to weigh the sudden loss against the company's previous modest gains this year.
Vancouver-based Equinox Gold saw production climb 11% to 176,836 ounces in the second quarter, a surge driven by the steady ramp-up of its key Canadian mining projects. The company’s performance reflects a broader push to stabilize operations at its newest facilities in Newfoundland and Labrador and Ontario.
Toronto-based Triple Flag Precious Metals outperformed analyst expectations in the second quarter, reporting $129.2 million in revenue. The surge marks a significant jump from the $94.1 million generated during the same period last year, fueled primarily by increased contributions from its core gold and silver streaming operations.
AstraZeneca shares plunged 9% in London morning trading today after the company confirmed its drug Wainua failed to meet primary objectives in a late-stage clinical trial. The setback for the transthyretin amyloid cardiomyopathy treatment forces investors to reconsider the company's aggressive growth targets for the remainder of the decade.
